An approach to the use of antihypertensive drugs in children and adolescents

Rames, 1978, Normal blood pressure and the evaluation of sustained blood pressure elevation in childhood: The Muscatine study, Pediatrics, 61, 245, 10.1542/peds.61.2.245 Fixler, 1983, Validity of mass blood pressure screening in children, Pediatrics, 72, 459, 10.1542/peds.72.4.459 Kilcoyne, 1974, Adolescent hypertension. I. Detection and prevalence, Circulation, 50, 758, 10.1161/01.CIR.50.4.758 Reichman, 1975, Hypertension testing among high school students. I. Surveillance procedures and results, J Chronic Dis, 28, 161, 10.1016/0021-9681(75)90004-1 Sinaiko, 1988, “Significant” diastolic hypertension in pre-high school black and white children. The children and adolescent blood pressure program, Am J Hypertens, 1, 178, 10.1093/ajh/1.2.178 1996, Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program, Pediatrics, 98, 649, 10.1542/peds.98.4.649 Verdecchia, 1999, White-coat hypertension in adults and children, Blood Press Monit, 4, 175, 10.1097/00126097-199903000-00013 Hornsby, 1991, “White-coat” hypertension in children, J Fam Pract, 33, 617 Reusz, 1994, 24 Hour blood pressure monitoring in healthy and hypertensive children, Arch Dis Child, 70, 90, 10.1136/adc.70.2.90 Gellermann, 1997, Twenty-four-hour ambulatory blood pressure monitoring in young children, Pediatr Nephrol, 11, 707, 10.1007/s004670050371 Sorof, 2000, Prevalence of white coat hypertension in children with elevated casual BP, Am J Hypertens, 13, 25A, 10.1016/S0895-7061(00)00391-5 Fixler, 1990, Ambulatory blood pressure monitoring in hypertensive adolescents, Am J Hypertens, 3, 288, 10.1093/ajh/3.4.288 Belsha, 1998, Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension, Am J Hypertens, 11, 410, 10.1016/S0895-7061(98)00014-4 White, 1999, Ambulatory blood pressure as a predictor of target organ disease and outcome in the hypertensive patient, Blood Press Monit, 4, 181, 10.1097/00126097-199903000-00014 Belsha, 1999, Ambulatory blood pressure monitoring and hypertensive target-organ damage in children, Blood Press Monit, 4, 161, 10.1097/00126097-199903000-00010 Hanna, 1991, Hypertension and the kidney, J Pediatr, 118, 327, 10.1016/S0022-3476(05)82143-2 McCrory, 1992, Definition, prevalence, and distribution of causes of hypertension, 104 1987, Report of the Second Task Force on Blood Pressure Control in Children—1987, 79, 1 Luepker, 1999, Secular trends of blood pressure and body size in a multi-ethnic adolescent population: 1986 to 1996, J Pediatr, 134, 668, 10.1016/S0022-3476(99)70279-9 Daniels, 1999, Is there an epidemic of cardiovascular disease on the horizon?, J Pediatr, 134, 665, 10.1016/S0022-3476(99)70277-5 Lever, 1992, Essential hypertension: A disorder of growth with origins in childhood?, J Hypertens, 10, 101, 10.1097/00004872-199202000-00001 de Simone, 1997, Relations of left ventricular geometry and function to body composition in children with casual high blood pressure, Hypertension, 30, 377, 10.1161/01.HYP.30.3.377 Okasha, 2000, Determinants of adolescent blood pressure: Findings from the Glasgow University student cohort, J Hum Hypertens, 14, 117, 10.1038/sj.jhh.1000948 Deal, 1992, Management of hypertensive emergencies, Arch Dis Child, 67, 1089, 10.1136/adc.67.9.1089 Daniels, 1987, Clinical spectrum of intrinsic renovascular hypertension in children, Pediatrics, 80, 698, 10.1542/peds.80.5.698 Daniels, 1990, Distribution of target-organ abnormalities by race and sex in children with essential hypertension, J Hum Hypertens, 4, 103 Daniels, 1999, Hypertension-induced cardiac damage in children and adolescents, Blood Press Monit, 4, 165, 10.1097/00126097-199903000-00011 Wells, 1999, Trials of antihypertensive therapies in children, Blood Press Monit, 4, 189 Rippley, 2000, Pharmacokinetics of enalapril in hypertensive children and infants, Am J Hypertens, 13, 126A, 10.1016/S0895-7061(00)00574-4 Soffer, 2000, Effects of the ACE inhibitor, enalapril, in children age 6–16 years with hypertension, Am J Hypertens, 13, 126A, 10.1016/S0895-7061(00)00575-6 Cunningham, 2000, A double-blind, placebo-controlled dose escalation safety and efficacy study of Ziac in patients, ages 6–17 years, with hypertension, Am J Hypertens, 13, 38A, 10.1016/S0895-7061(00)00390-3 2000 Temple, 2000, Treatment of pediatric hypertension, Pharmacotherapy, 20, 140, 10.1592/phco.20.3.140.34782 Miller, 1994, Pharmacological management of hypertension in paediatric patients: A comprehensive review of the efficacy, safety and dosage guidelines of the available agents, Drugs, 48, 868, 10.2165/00003495-199448060-00004 Tifft, 2000, Joint National Committee VI: Individualized versus indiscriminate therapy for hypertension, Curr Hypertens Rep, 2, 243, 10.1007/s11906-000-0006-2 1997, The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, Arch Intern Med, 157, 2413, 10.1001/archinte.1997.00440420033005 1999, 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension, J Hypertens, 17, 151 1977, Report of the Task Force on Blood Pressure Control in Children, Pediatrics, 59, 797 Sinaiko, 1996, Hypertension in children, N Engl J Med, 335, 1968, 10.1056/NEJM199612263352607 Feld, 1999, Treatment of hypertension, 1031 1994, Working group report on hypertension in diabetes, Hypertension, 23, 145, 10.1161/01.HYP.23.2.145 Hansson, 1998, Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial, Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6 Wiklund, 1997, Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study, Blood Press, 6, 357, 10.3109/08037059709062095 Sever, 1999, Recent clinical trials: A critical appraisal, Curr Hypertens Rep, 1, 333, 10.1007/s11906-999-0042-5 Neal, 1999, Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments, Curr Hypertens Rep, 1, 346, 10.1007/s11906-999-0045-2 Elliott, 2000, Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, Curr Hypertens Rep, 2, 402, 10.1007/s11906-000-0045-8 Sever, 2000, Coronary heart disease prevention as the primary goal in contemporary trials in the treatment of hypertension, Curr Hypertens Rep, 2, 418, 10.1007/s11906-000-0047-6 Messerli, 2000, Doxazosin arm of the ALLHAT study discontinued: How equal are antihypertensive drugs? Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial, Curr Hypertens Rep, 2, 241, 10.1007/s11906-000-0005-3 Psaty, 1995, The risk of myocardial infarction associated with antihypertensive drug therapies, JAMA, 274, 620, 10.1001/jama.1995.03530080036038 Laragh, 1989, Issues, goals, and guidelines in selecting first-line drug therapy for hypertension, Hypertension, 13, I103, 10.1161/01.HYP.13.5_Suppl.I103 1993, The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, Arch Intern Med, 153, 154, 10.1001/archinte.1993.00410020010002 Nahata, 1997 1997, IMS America Database, Dun and Bradstreet Adelman, 2000, The emergency management of severe hypertension, Pediatr Nephrol, 14, 422, 10.1007/s004670050787 Willems, 1985, Brain revascularisation in hypertension, Arch Dis Child, 60, 1177, 10.1136/adc.60.12.1177 1999, 651 Treluyer, 1993, Intravenous nicardipine in hypertensive children, Eur J Pediatr, 152, 712, 10.1007/BF01953981 2000 2000 Bunchman, 1992, Intravenously administered labetalol for treatment of hypertension in children, J Pediatr, 120, 140, 10.1016/S0022-3476(05)80619-5 Dillon, 1984, Modern management of hypertension, 35 Feld, 1988, Hypertension in children, Curr Probl Pediatr, 18, 317, 10.1016/0045-9380(88)90025-4 Sinaiko, 1994, Treatment of hypertension in children, Pediatr Nephrol, 8, 603, 10.1007/BF00858144 Truttmann, 1998, A moratorium should be placed on the use of short-acting nifedipine for hypertensive crises, Pediatr Nephrol, 12, 259 Flynn, 2000, Neonatal hypertension: Diagnosis and management, Pediatr Nephrol, 14, 332, 10.1007/s004670050771 Savage, 2000, Use of short acting nifedipine in pediatric patients with hypertension, J Invest Med, 48, 130A Oberfield, 1979, Use of angiotensin I-converting enzyme inhibitor (captopril) in childhood malignant hypertension, J Pediatr, 95, 641, 10.1016/S0022-3476(79)80787-8 Strife, 1986, Minoxidil for control of acute blood pressure elevation in chronically hypertensive children, Pediatrics, 78, 861, 10.1542/peds.78.5.861 Casalini, 1995, Two-year clinical follow-up of children and adolescents after percutaneous transluminal angioplasty for renovascular hypertension, Invest Radiol, 30, 40, 10.1097/00004424-199501000-00006 Norling, 1992, Use of interventional radiology for hypertension due to renal artery stenosis in children, Child Nephrol Urol, 12, 162 O'Neill, 1995, Midaortic syndrome and hypertension in childhood, J Pediatr Surg, 30, 164, 10.1016/0022-3468(95)90555-3 Stanley, 1995, Pediatric renovascular hypertension: A thirty-year experience of operative treatment, J Vasc Surg, 21, 212, 10.1016/S0741-5214(95)70263-6 Wells, 1996, Pediatric renovascular hypertension, Curr Opin Pediatr, 8, 128, 10.1097/00008480-199604000-00008 Rosenthal, 1993, Drug therapy of renovascular hypertension, Drugs, 45, 895, 10.2165/00003495-199345060-00003 Wood, 1991, Captopril-induced reversible acute renal failure in an infant with coarctation of the aorta, Pediatrics, 88, 816, 10.1542/peds.88.4.816 Ingelfinger JR, Wells TG. Use of enalapril and enalaprilat in pediatric hypertension and renal disease. Pediatr Nephrol. In press. Guignard, 1999, Clinical neonatal nephrology, 1051 Wells, 1990, The pharmacology and therapeutics of diuretics in the pediatric patient, Pediatr Clin North Am, 37, 463, 10.1016/S0031-3955(16)36880-8 Lin, 1998, Inhibition and induction of cytochrome P450 and the clinical implications, Clin Pharmacokinet, 35, 361, 10.2165/00003088-199835050-00003 Lacroix, 1997, Expression of CYP3A in the human liver-evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth, Eur J Biochem, 247, 625, 10.1111/j.1432-1033.1997.00625.x Sinaiko, 1993, Pharmacologic management of childhood hypertension, Pediatr Clin North Am, 40, 195, 10.1016/S0031-3955(16)38490-5 Wells, 1990, Treatment of neonatal hypertension with enalaprilat, J Pediatr, 117, 664, 10.1016/S0022-3476(05)80711-5 Perlman, 1989, Neurologic complications of captopril treatment of neonatal hypertension, Pediatrics, 83, 47 Tack, 1988, Renal failure in sick hypertensive premature infants receiving captopril therapy, J Pediatr, 112, 805, 10.1016/S0022-3476(88)83213-X Sinaiko, 1983, Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease, J Pediatr, 103, 799, 10.1016/S0022-3476(83)80490-9 1997, Athletic participation by children and adolescents who have systemic hypertension, Pediatrics, 99, 637, 10.1542/peds.99.4.637 Frishman, 1997, Alpha- and beta-adrenergic blocking drugs, 59 Vanhees, 2000, Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men, J Hypertens, 18, 35, 10.1097/00004872-200018010-00006 Alper, 1999, Contemporary management of refractory hypertension, Curr Hypertens Rep, 1, 402, 10.1007/s11906-999-0055-0 Saken, 1979, Drug-induced hypertension in infancy, J Pediatr, 95, 1077, 10.1016/S0022-3476(79)80316-9 Joss, 1982, Hypertension and convulsions in children receiving cyclosporin A, Lancet, 1, 906, 10.1016/S0140-6736(82)92171-7